еНаука - преглед
Преглед према Аутор Trukhin, Dmytro
Приказ резултата 1 до 4 од 4
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
|---|---|---|---|---|
| 2021 | Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis. | Trukhin, Dmytro; Poddubskaya, Elena; Andric, Zoran G   ; Bondarenko, Igor N; Shevnia, Serhii; Zaric, Bojan ; Bellala, Ravishankar; Charoentum, Chaiyut; Perez, Luis; Bullo, Felicitas;
Garcia, Fernanda;
| Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2020 | Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study. | Millan, Susana; Trukhin, Dmytro; Kolesnik, Oleksii; Poddubskaya, Elena; Andric, Zoran G ; Bondarenko, Igor N; Shevnia, Serhii; Bullo, Felicitas; Sarnago, Cristina | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2021 | Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) | Syrigos, Konstantinos; Abert, Istvan; Andric, Zoran G ; Bondarenko, Igor N; Dvorkin, Mikhail; Galic, Kristina; Galiulin, Rinat; Kuchava, Vladimer; Sriuranpong, Virote; Trukhin, Dmytro;
Zhavrid, Edvard; Fu, Dongyue; Kassalow, Laurent M; Jones, Stephanie; Bashir, Zahid;
| Article | 21aM21a |
| 2021 | Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA) | Trukhin, Dmytro; ...; Andric, Zoran G ; ...; (broj, koautora 19) | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |